Bank of America
ENFN

Bank of America’s Enfusion, Inc. ENFN Stock Holding History

Bank of America’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-672,628
Closed -$7.5M – 8774
2025
Q1 		$7.5M Buy
672,628
+316,477
+89% +$3.5M ﹤0.01% 3433
2024
Q4 		$3.67M Sell
356,151
-242,629
-41% -$2.35M ﹤0.01% 3878
2024
Q3 		$5.68M Buy
598,780
+19,073
+3% +$165K ﹤0.01% 3619
2024
Q2 		$4.94M Sell
579,707
-165,753
-22% -$1.52M ﹤0.01% 3635
2024
Q1 		$6.9M Buy
745,460
+342,632
+85% +$3.01M ﹤0.01% 3327
2023
Q4 		$3.91M Buy
402,828
+148,185
+58% +$1.38M ﹤0.01% 3754
2023
Q3 		$2.28M Buy
254,643
+26,456
+12% +$251K ﹤0.01% 4121
2023
Q2 		$2.56M Buy
228,187
+118,437
+108% +$1.05M ﹤0.01% 3991
2023
Q1 		$1.15M Sell
109,750
-83,851
-43% -$924K ﹤0.01% 4799
2022
Q4 		$1.87M Buy
193,601
+147,347
+319% +$1.66M ﹤0.01% 4314
2022
Q3 		$570K Sell
46,254
-11,148
-19% -$136K ﹤0.01% 5304
2022
Q2 		$586K Sell
57,402
-7,578
-12% -$83.7K ﹤0.01% 5313
2022
Q1 		$827K Buy
64,980
+54,754
+535% +$836K ﹤0.01% 5424
2021
Q4 		$214K Buy
+10,226
New +$207K ﹤0.01% 6465

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's ENFN Position: Q2 2025 in Review

Bank of America sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 672,628 shares — an estimated $7.5M sold.

Bank of America first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $7.5M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Bank of America reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 672,628 Enfusion, Inc. shares in Q2 2025, an estimated $7.5M.
  • Bank of America first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Bank of America's Enfusion, Inc. position peaked at $7.5M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.